moxifloxacin has been researched along with n-vinyl-2-pyrrolidinone in 2 studies
| Studies (moxifloxacin) | Trials (moxifloxacin) | Recent Studies (post-2010) (moxifloxacin) | Studies (n-vinyl-2-pyrrolidinone) | Trials (n-vinyl-2-pyrrolidinone) | Recent Studies (post-2010) (n-vinyl-2-pyrrolidinone) |
|---|---|---|---|---|---|
| 3,157 | 552 | 1,690 | 7,533 | 228 | 2,213 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balaguer-Fernández, C; Calatayud-Pascual, MA; López-Castellano, A; Rodilla, V; Sebastián-Morelló, M | 1 |
| Büyükköroğlu, G; Kırımlıoğlu, GY; Özer, S; Yazan, Y | 1 |
2 other study(ies) available for moxifloxacin and n-vinyl-2-pyrrolidinone
| Article | Year |
|---|---|
Ex vivo rabbit cornea diffusion studies with a soluble insert of moxifloxacin.
Topics: Administration, Ophthalmic; Animals; Anti-Bacterial Agents; Cornea; Diffusion; Drug Delivery Systems; Female; Fluoroquinolones; Glycerol; Hypromellose Derivatives; Male; Moxifloxacin; Polyethylene Glycols; Povidone; Rabbits | 2018 |
Moxifloxacin Hydrochloride-Loaded Eudragit® RL 100 and Kollidon® SR Based Nanoparticles: Formulation, In vitro Characterization and Cytotoxicity.
Topics: 3T3 Cells; Animals; Cell Survival; Dose-Response Relationship, Drug; Drug Carriers; Drug Compounding; Drug Liberation; Kinetics; Mice; Moxifloxacin; Nanoparticles; Particle Size; Polymethacrylic Acids; Povidone | 2021 |